证券记录 · 已归档季度
CVS
CVS Health Corp. · Healthcare · Medical - Healthcare Plans
31被追踪持有人
+1Δ持有人
672.14M持有股份
$50.66B报告持仓市值
+1新建仓位
−1清仓
动量输入（同类管理人）：
持有人广度 +3.3% ·
股份流向 +0.4% ·
净新建仓位 0.0%
· 公式
广泛增持：持股数量上升，持有人数量增加
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 4 | +1 | 4.62M | $393.86M | +1 | −2 |
| Q2 2026 | 181 | +1 | 951.14M | $98.28B | +4 | −4 |
| Q1 2026 | 184 | -5 | 933.53M | $67.00B | +1 | −7 |
| Q4 2025 | 188 | -1 | 988.04M | $78.39B | +1 | −1 |
| Q3 2025 | 31 | +1 | 672.14M | $50.66B | +1 | −1 |
| Q2 2025 | 28 | +1 | 592.40M | $40.85B | +1 | n/a |
| Q1 2025 | 24 | 0 | 305.08M | $20.66B | +1 | −1 |
| Q4 2024 | 24 | -1 | 290.03M | $13.02B | +1 | −2 |
| Q3 2024 | 24 | +2 | 213.06M | $13.39B | +3 | −1 |
| Q2 2024 | 22 | n/a | 197.40M | $11.65B | n/a | n/a |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (被动) | 119.84M | -2.3% | $9.03B | 0.2% | ▼ Trim | 2 | SEC ↗ ×22 |
| 2 | The Vanguard Group ✦ (被动) | 118.89M | -1.3% | $8.96B | 0.1% | ▼ Trim | 2 | SEC ↗ ×6 |
| 3 | Dodge & Cox ✦ | 73.18M | -0.1% | $5.52B | 3.0% | ▼ Trim | 6 | SEC ↗ |
| 4 | JPMorgan Chase ✦ | 70.55M | n/a | $5.32B | 0.2% | n/c | 1 | SEC ↗ ×42 |
| 5 | Capital World Investors ✦ | 68.38M | +2.1% | $5.16B | 0.7% | ▲ Add | 6 | SEC ↗ |
| 6 | State Street Global Advisors ✦ (被动) | 58.94M | +0.2% | $4.44B | 0.2% | ▲ Add | 4 | SEC ↗ |
| 7 | Fidelity (FMR) ✦ | 43.34M | -5.0% | $3.27B | 0.2% | ▼ Trim | 2 | SEC ↗ ×7 |
| 8 | Geode Capital Management ✦ (被动) | 28.99M | +1.2% | $2.18B | 0.1% | ▲ Add | 6 | SEC ↗ ×2 |
| 9 | Morgan Stanley ✦ | 19.16M | n/a | $1.44B | 0.1% | n/c | 1 | SEC ↗ ×19 |
| 10 | T. Rowe Price ✦ | 17.40M | +4.7% | $1.31B | 0.1% | ▲ Add | 6 | SEC ↗ ×2 |
| 11 | Glenview Capital ✦ | 8.20M | 0.0% | $617.96M | 15.0% | Held | 6 | SEC ↗ |
| 12 | Goldman Sachs Group ✦ | 7.16M | n/a | $540.10M | 0.1% | n/c | 1 | SEC ↗ ×5 |
| 13 | Wellington Management ✦ | 6.33M | +391.6% | $477.27M | 0.1% | ▲ Add | 6 | SEC ↗ ×8 |
| 14 | Millennium Management ✦ | 5.38M | +32.2% | $405.46M | 0.3% | ▲ Add | 6 | SEC ↗ |
| 15 | Arrowstreet Capital ✦ | 5.29M | +70.5% | $399.12M | 0.3% | ▲ Add | 6 | SEC ↗ |
| 16 | Marshall Wace ✦ | 3.66M | +111.3% | $276.28M | 0.3% | ▲ Add | 6 | SEC ↗ ×2 |
| 17 | Citadel Advisors ✦ | 3.22M | -60.6% | $242.54M | 0.2% | ▼ Trim | 6 | SEC ↗ ×2 |
| 18 | AQR Capital Management ✦ | 3.05M | +34.0% | $230.15M | 0.1% | ▲ Add | 6 | SEC ↗ ×7 |
| 19 | Fairfax Financial ✦ | 2.71M | 0.0% | $204.38M | 9.9% | Held | 4 | SEC ↗ |
| 20 | PRIMECAP Management ✦ | 2.67M | -8.8% | $201.43M | 0.2% | ▼ Trim | 6 | SEC ↗ |
| 21 | Adage Capital Partners ✦ | 1.87M | +16.3% | $141.08M | 0.2% | ▲ Add | 6 | SEC ↗ |
| 22 | Bridgewater Associates ✦ | 1.19M | +42.6% | $89.95M | 0.4% | ▲ Add | 6 | SEC ↗ |
| 23 | D. E. Shaw & Co. ✦ | 1.12M | +20.6% | $84.30M | 0.1% | ▲ Add | 6 | SEC ↗ ×3 |
| 24 | Harris Associates (Oakmark) ✦ | 548.57K | -35.0% | $41.36M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 25 | Point72 Asset Management ✦ | 426.09K | 新增 | $32.12M | 0.1% | New | 1 | SEC ↗ |
| 26 | Gotham Asset Management ✦ | 236.00K | +33.8% | $17.79M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 27 | Renaissance Technologies ✦ | 160.90K | -72.4% | $12.13M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 28 | GAMCO Investors ✦ | 127.48K | -3.3% | $9.61M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 29 | Fisher Asset Management ✦ | 89.10K | -5.3% | $6.72M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 30 | Two Sigma Investments ✦ | 23.07K | +1.7% | $1.74M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 31 | Tweedy, Browne ✦ | 10.36K | +104.6% | $780,814 | 0.1% | ▲ Add | 2 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Point72 Asset Management | $32.12M | 0.1% |
已清仓
| Norges Bank | $1.36B | 曾为 0.2% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 1,848 持有人, 1.07B 股份, $73.55B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据